You are here

P&T® Journal contents for June 2010

Features

Health Care & Law
A closely watched legal decision raises the question of whether companies will be able to protect their ownership of genetic information.
Robert I. Field, JD, MPH, PhD
Drug Review
A Practical Review for Pharmacists
Dr. Craig describes the drug’s pharmacology, pharmacokinetics, efficacy, and safety; the process of switching from other agents; and ways ­pharmacists can help prevent abuse of this controlled substance.
David S. Craig, PharmD, BCPS
Meeting Highlights
Neurology topics include Guillain-Barré syndrome after H1N1 vaccine administration, sodium oxybate for fibromyalgia, and botulinum neurotoxin type A (NT-201) for dystonias. Angiotensin-receptor blocker combinations for hypertension include phentermine/topiramate, amlodipine/olmesartan, and chlorthalidone/azilsartan.
Walter Alexander
Sipuleucel-T (Provenge) for prostate cancer, polidocanol (Asclera) for varicose veins, and imiquimod cream 3.75% (Zyclara) for actinic keratoses are discussed.
Marvin M. Goldenberg, PhD, RPh, MS
Continuing Education Credit
A chronic inflammation of the skin, seborrheic dermatitis affects more than 11% of people and almost 70% of infants. The authors discuss various drug and non-drug therapies and the role of the pharmacist in counseling patients about this condition and its treatment.
Thomas Berk, MD, and Noah Scheinfeld, MD

Departments

Editorial
A former American President has inspired our editor-in-chief to reflect on our global economy and interdependence.
David B. Nash, MD, MBA
Medication Errors
Preventing catastrophic events requires transforming the culture of patient safety.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Stephen Barlas explains why many pharmacists are not being helped by the FDA’s ­latest guidance on authenticating drug packages.
Stephen Barlas
P&T presents FDA approvals, drug indications, product recalls, and devices in the news.
Drug Forecast
Immediate-release tapentadol (Nucynta) for moderate-to-severe pain is discussed.
Bazhena Fidman, PharmD Candidate, and Anna Nogid, BS, PharmD, BCPS